ReviewMolecular biology reports2025
Emerging landscape of lncRNA-miRNA interactions as architects of gene expression patterns.
Review in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Long non-coding RNAs in glial cells: key drivers of neuroinflammation in cognitive disorders.Frontiers in aging neuroscience · 2026Pooled it
- Molecular Signature and miRNA Pattern of CD4 + T Lymphocytes in Plaque Psoriasis.Clinical reviews in allergy & immunology · 2026Review
- Pan-cancer and single-cell analysis identifies MAGI2-AS3 as an immune regulator and prognostic biomarker with a focus on colorectal cancer.Discover oncology · 2026Article
- A new approach for understanding the association between chronic stress in childhood and psychotic symptoms in schizophrenia patients from mediating role of lncRNA.Schizophrenia (Heidelberg, Germany) · 2026Article
- Comparative Transcriptomic and ceRNA Network Analyses of Non-Coding and Coding RNAs in Heads ofInternational journal of molecular sciences · 2026Article
- Unravelling the nexus of non-coding RNAs in cancer stemness and therapeutic drug resistance.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eukaryotic genome is highly complex and intricately organized, with nearly 98% of the human genome consisting of non-protein coding regions. Over the past few decades, extensive research has revealed a wealth of information within these non-coding elements, leading to the identification of various non-coding RNAs, including microRNAs (miRNAs), PIWI-interacting RNAs (piRNAs), long non-coding RNAs (lncRNAs), and other regulatory RNAs. Among these, lncRNAs have emerged as crucial regulators of diverse biological processes such as chromatin remodelling, transcriptional regulation, and epigenetic control. A particularly significant aspect of lncRNA function is their interaction with miRNAs, where they act as molecular scaffolds, decoys, guides, or sponges, modulating miRNA activity and influencing gene expression. These lncRNA-miRNA interactions play critical roles in regulating cellular pathways and have important implications in the onset and progression of diseases, including cancer, cardiovascular disorders, and neurodegenerative diseases. This review provides a comprehensive analysis of lncRNA biogenesis, their functional mechanisms, and their diverse roles in transcriptional and post-transcriptional regulation, with a special focus on the dynamic interplay between lncRNAs and miRNAs in gene regulation and disease progression.
Indexed as
Identifiers
40778999What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.